Among the 117 patients, the downregulation of FOXO3a expression showed statistically significant correlations with an aggressive FIGO stage (P = 0.001), histologic grade (P = 0.035), and lymph node metastasis (P = 0.007, Table 1). The gene discussed is FOXO3; the disease is metastatic malignant neoplasm in the lymph nodes.